ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,203, issued on Dec. 9, was assigned to K36 Therapeutics Inc. (Cambridge, Mass.).
"Deuterium-enriched piperidinyl-methyl-purine amines and related compounds and their use in treating diseases and conditions" was invented by Terrence Joseph Connolly (Concord, Mass.) and Chad Arthur Lewis (Boylston, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides deuterium-enriched piperidinyl-methyl-purine amines and related compounds, pharmaceutical compositions, their use for inhibiting NSD2, and their use in the treatment of a disease or condition, such as cancer."
The patent was filed on June 28, 2024, under Application No. 18/758,953....